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(12%). Perioperative MI was recorded among 1 patient
(4%). While all arterial grafts 27 (100%) were classified
as patent, 51 venous grafts (89%) were considered as pat-
ent where 11% of venous grafts were considered as non
patent. All the significant stenosis were found in the body
of venous graft.
Conclusion: Extensive reconstruction of the diffusely
diseased LAD using an ITA graft could be performed
safely with very encouraging results. MDCT angiography
is an excellent non invasive tool not only to evaluate graft
patency in the reconstructed LAD but also to detect other
findings in asymptomatic patients with diffuse coronary
artery disease for better and more close follow up. To
our knowledge, this may be the first study to examine
surgically reconstructed diffusely diseased LAD with
MDCT.
http://dx.doi:10.1016/j.jsha.2013.03.006
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Aim: The aim of the study was to investigate the
Plasminogen activator inhibitor-1 (PAI-1) expression in
obese children and to clarify its role with respect to left
ventricular (LV) function.
Patients and methods: This study included 69
obese children and adolescents, 40 lean healthy controls.
Children were considered obese according to body mass
index (BMI) percentile for age and sex curves of growth
for our population. Each subject’s fat distribution was
assessed by measuring waist hip ratio (WHR). Obese
children with peripheral fat distribution were excluded.
Exclusion criteria included hypertension, endocrine, car-
diovascular, renal, insulin dependent or independent
diabetes mellitus and smoking habits. Laboratory investi-
gations included measurement of plasma PAI-1 antigen.
Determination of total serum cholesterol, low density
lipoprotein, high density lipoprotein, triglycerides, blood
glucose and fasting serum insulin. Echocardiography
study was obtained by two dimensionally guided M
mode.
Results: BMI and WHR were significantly higher in
obese compared to lean children (P < 0.001). In addition
fasting blood glucose, fasting insulin, HOMA and triglyc-
eride were significantly higher in obese than in lean chil-
dren. Left ventricular mass (LVM) and LVM/H were
significantly higher in obese compared to controls
(P < 0.001) while left ventricular systolic (EF%, FS %)
and diastolic function (E/A ratio, decceleration time)
did not differ between the two groups (P > 0.05). Plasma
PAI-1 were significantly higher in obese compared to
controls (P = 0.03). A significant direct correlation was
revealed between PAI-1 in comparison to WHR, fasting
insulin and LVM/H. Plasma PAI -1 and WHR were inde-
pendent predictors of LVM/H.
Conclusions: Obese children with central fat distri-
bution showed an increase in plasma PAI-1 antigen. Also
PAI-1 contributes directly to the complication of obesity
including type 2 diabetes and cardiovascular disease.
http://dx.doi:10.1016/j.jsha.2013.03.007
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Aim: The aim of the study was to evaluate cardiac
function and epicardial adipose tissue (EAT) of obese
children with echocardiography and to study the rela-
tionship of EAT to other echocardiogrpahic findings
and to clinical parameters of metabolic syndrome(MS)
in children.
Patients and methods: This study included 74
obese children and adolescents form the patients attend-
ing the obesity clinic of National Research Centre. Meta-
bolic syndrome was determined according to
International Obesity Task Force (IOTF) 2007 criteria.
Forty leanchildren were included in the study as a control
group. All children were subjected to: clinical assessment
including standing height, body weight, body mass index
(BMI), waist circumference (WC), hip circumference
(HC), systolic blood pressure (SBP) and diastolic blood
pressure (DBP). Echocardiography examination with
measurement of EAT thickness and Biochemical param-
eters (fasting glucose, insulin, HOMA index, total choles-
terol, triglyceride, HDL-C and LDL-C).
Results: BMI, SDS BMI, WC, HC and HOMA index
were significantly higher in obese compared to lean chil-
dren P = 0.001. Left atrial (LA) diameter, septal, posterior
wall thickness, relative wall thickness and left ventricular
mass (LVM) were increased in obese compared to non
obese group while LV systolic and diastolic functions
did not differ in obese versus lean children P > 0.05.
The patients had significantly thicker EAT compared to
control P = 0.01. There was a significant correlation
between EAT thickness in comparison to BMI, WC, HC,
LA diameter, LVM, HOMA, Triglyceride and LDL-C No
significant difference in EAT thickness between obese
patients with or without metabolic syndrome.
Conclusion: Assessment of EAT thickness in routine
echocardiographic examinations might be a feasible and
reliable method for the evaluation of obesity and its
related cardiovascular risks during childhood. There is
no significant association between EAT thickness and
metabolic syndrome in obese children.
http://dx.doi:10.1016/j.jsha.2013.03.008
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